Mid-Year Tier Creep: How Your Insurer Can Quietly Move Your Drug to a More Expensive Category

When you enrolled in your current health plan, you likely checked whether your medications were covered and at what tier. A Tier 1 or Tier 2 placement meant a manageable copay. You built your monthly budget around that number. What many insured Americans do not realize is that the tier assignment you confirmed at enrollment is not guaranteed to hold for the duration of the plan year.

Insurance plans — particularly those offered through employers and the individual marketplace — retain the authority to modify their formularies during the plan year under a range of circumstances. When a medication moves from Tier 2 to Tier 3, or from Tier 3 to Tier 4, the cost difference for the patient can be substantial: often the difference between a twenty-dollar copay and a one-hundred-and-fifty-dollar coinsurance payment for a single monthly fill.

What the Regulations Actually Allow

The regulatory framework governing mid-year formulary changes is more permissive than most consumers assume. Under the Affordable Care Act and its implementing regulations, health plans are generally required to maintain their formularies as filed at the start of the plan year. However, the regulations carve out several exceptions that, in practice, give plans meaningful flexibility to alter drug coverage during the year.

Plans may move a medication to a higher tier mid-year if the drug's manufacturer raises its list price, if a generic equivalent becomes available, if the plan's PBM renegotiates its rebate arrangement with the manufacturer, or if the plan determines that utilization patterns justify a coverage restructuring. The notification requirements attached to these changes are limited: for most plan types, a sixty-day advance notice to affected members is required, but enforcement of this requirement is inconsistent, and many consumers report learning of tier changes only when they arrive at the pharmacy.

Medicare Part D plans operate under somewhat stricter rules — they are generally prohibited from moving a drug to a higher tier or removing it from the formulary mid-year for beneficiaries who are actively taking the medication. But employer-sponsored plans and ACA marketplace plans do not carry this same protection, leaving the majority of commercially insured Americans exposed to mid-year tier adjustments.

Medications That Have Moved — and What It Cost Patients

Tier reclassifications are not hypothetical. Several categories of medications have been subject to significant tier migration in recent years, often tracking shifts in the commercial rebate environment.

Insulins represent one of the most consequential examples. As biosimilar insulins entered the market and manufacturer rebate structures shifted, multiple major insurers restructured their insulin tier placements — in some cases moving brand-name insulins to higher tiers while placing biosimilars at lower tiers, and in others making adjustments that increased costs for patients who had stabilized on a particular product. Patients who had managed their costs around a specific tier assignment found themselves facing sharply higher bills mid-year.

Atypical antipsychotics, specialty biologics for autoimmune conditions, and certain cardiovascular medications have all experienced notable tier migration events in recent plan years. In each case, the patients most affected were those on long-term stable regimens who had least reason to anticipate a change.

Building a Formulary Monitoring System

Proactive monitoring is the most effective defense against unexpected tier changes. The following approach can help you stay ahead of reclassifications before they reach your pharmacy receipt.

Bookmark your plan's formulary page. Every insurer is required to maintain an online, searchable formulary. Find the specific page for your plan's current formulary — not the general plan information page — and bookmark it. Check it monthly for your maintenance medications.

Set a calendar reminder for the sixty-day notification window. If your insurer is required to provide sixty days' notice of a tier change, a mid-year notification arriving in June means the change takes effect in August. Knowing this timeline gives you a window to act before the new cost structure applies.

Review your Explanation of Benefits after each fill. Your EOB will show the tier under which your medication was processed. If the tier designation changes between fills, you have documentary evidence of the reclassification that can support a coverage appeal.

Sign up for plan communications. Many insurers send formulary change notifications by email or through their member portal. Ensuring that your contact preferences are current and that you are opted in to plan communications is a basic but frequently overlooked precaution.

Challenging a Tier Reclassification

When a tier change occurs, consumers have several avenues for contesting the new cost structure.

File a formulary exception request. Most plans are required to have a process for requesting a formulary exception — a determination that a specific medication should be covered at a lower tier based on medical necessity. Your prescribing physician will need to submit documentation supporting the exception, explaining why the reclassified drug is medically necessary and why lower-tier alternatives are not appropriate for your specific situation.

Request a transition supply. If you are a long-term user of a medication that has been reclassified or removed from the formulary, many plans are required to provide a temporary supply at the prior cost-sharing level while your exception request is processed. Ask your insurer's member services department about transition supply provisions.

Escalate to your state insurance commissioner. If your insurer failed to provide required notice of a tier change, or if your exception request was denied without adequate justification, filing a complaint with your state's department of insurance can prompt a formal review. State insurance commissioners have authority to require plans to justify their formulary decisions and, in some cases, to reverse improper reclassifications.

Explore alternative coverage options. If a tier reclassification makes a medication genuinely unaffordable and your exception request is denied, it is worth investigating whether the drug's manufacturer offers a patient assistance program, whether a manufacturer copay card can offset the higher tier cost, and whether a different plan available through your employer or the marketplace would offer better tier placement for that medication during the next open enrollment period.

A Note on Coupon Card Caution

One common response to a tier reclassification is to use a manufacturer copay card or a discount program to offset the higher cost. This can be effective in the short term, but it carries an important caveat: using a manufacturer coupon typically means your payment does not count toward your deductible or out-of-pocket maximum. If you are close to hitting your annual out-of-pocket limit, paying the higher tier cost through your insurance — even if it is painful in the short term — may ultimately cost you less over the full plan year than bypassing your insurance with a coupon.

Staying in Control of Your Formulary

Formulary tier reclassifications are a structural feature of the commercial insurance market, not an exceptional event. For consumers on maintenance medications, the question is not whether a tier change might affect them, but when. Approaching formulary monitoring as a routine financial habit — alongside reviewing bank statements and checking credit reports — is the most reliable way to ensure that a quiet administrative change does not translate into an unexpected and avoidable increase in your annual prescription costs.